SABCS 2021 Conference Coverage on VuMedi


 

SABCS 2021 Update on the KEYNOTE-522 Trial of Neoadjuvant Pembro+Chemo vs. Placebo+Chemo Followed by Adjuvant Pembro vs. Placebo in eTNBC: EFS Sensitivity & Subgroup Analyses

235 views
January 17, 2022
Comments 0
Login to view comments. Click here to Login